about
A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.Immunotherapy for the treatment of breast cancer.Sensitivity to Restimulation-Induced Cell Death Is Linked to Glycolytic Metabolism in Human T Cells.The correlation between the subsets of tumor infiltrating memory T cells and the expression of indoleamine 2,3-dioxygenase in gastric cancer.
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Rapamycin: could it enhance vaccine efficacy?
@en
Rapamycin: could it enhance vaccine efficacy?
@nl
type
label
Rapamycin: could it enhance vaccine efficacy?
@en
Rapamycin: could it enhance vaccine efficacy?
@nl
prefLabel
Rapamycin: could it enhance vaccine efficacy?
@en
Rapamycin: could it enhance vaccine efficacy?
@nl
P2860
P356
P1476
Rapamycin: could it enhance vaccine efficacy?
@en
P2093
Jae-Hwan Nam
P2860
P304
P356
10.1586/ERV.09.115
P577
2009-11-01T00:00:00Z